Is This Red-Hot New “Blood Stock” Any Bloody Good as an Investment?
[Ed. Note: Dr. KSS writes about biotech stocks for the Irregulars. We have not reviewed or approved his topics or opinions, and he has agreed to our trade restrictions. Enjoy!] Twenty years ago, I was...
View ArticleThe Gain from Pain Mainly Explained: Fire Walk with Me
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. This article is third in a series on pain. You can see the first part here, and second part here. His words and opinions...
View ArticleDawn of the Planet of the TLOGlodytes!
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own, and he has agreed to our trading restrictions.] Want to see something really cool? A...
View ArticleBiotech Dim Sum: ARTH, CLDN, ESPR, BLRX, GILD and a New Baby Biotech for 2015
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. His previous...
View ArticleGumshoe BioDimSum II: Corralling the “A” Biotechs Plus a New Long Selection
[Ed. Note: Dr. KSS writes for our Irregulars about medicine and biotech stocks. As always, he has agreed our trading restrictions, and his words and opinions are his own. You can find all of his...
View Article
More Pages to Explore .....